While treating an HIV-infected patient for lung cancer, a cancer drug caused a “drastic and persistent decrease” in viral reservoirs, raising hopes of a new HIV treatment.

Doctors at the Pitie-Salpetriere Hospital in Paris may have found a cancer therapy that is also a highly effective human immunodeficiency virus (HIV) treatment. In a letter written to Annals of Oncology, the group explained that a cancer drug, nivolumab, a drug sold by Bristol Myers Squibb under the tradename Opdivo, dramatically reduced HIV reservoirs.

Read the full articel at labiotech.eu

Stay informed

about new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice